Epilepsy

This educational resource is designed to provide healthcare professionals with the tools to aid in the diagnosis and treatment of Developmental & Epileptic Encephalopathies like Dravet Syndrome and Lennox-Gastaut Syndrome. Find useful infographics, articles, and video commentaries from leaders in the field to help in understanding these conditions.

Hear this panel discussion featuring clinician experts in epilepsy as they discuss the identification, diagnosis, and treatment of children and adults with Lennox-Gastaut syndrome.

Learn more about the fenfluramine mechanism of action. Fenfluramine targets the serotonergic system and sigma-1 receptors. The precise mechanism by which fenfluramine exerts its therapeutic effects in the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome is unknown. The clinical relevance of mechanism of action is unknown.

Learn about consensus recommendations from The Seizure Termination Project, a world-renowned expert working group comprised of 12 epileptologists, neurologists, and pharmacologists from Europe and North America, on evidence-based definitions and guidelines for the management of prolonged seizures and seizure clusters.

Listen to respected clinician experts in epilepsy discuss progression of our understanding around seizure emergencies, available treatments for terminating a seizure emergency, and the importance of seizure action plans in all phases of life.